Human β-defensin 3 gene modification promotes the osteogenic differentiation of human periodontal ligament cells and bone repair in periodontitis

Abstract

Efforts to control inflammation and achieve better tissue repair in the treatment of periodontitis have been ongoing for years. Human β-defensin 3, a broad-spectrum antimicrobial peptide has been proven to have a variety of biological functions in periodontitis; however, relatively few reports have addressed the effects of human periodontal ligament cells (hPDLCs) on osteogenic differentiation. In this study, we evaluated the osteogenic effects of hPDLCs with an adenoviral vector encoding human β-defensin 3 in an inflammatory microenvironment. Then human β-defensin 3 gene-modified rat periodontal ligament cells were transplanted into rats with experimental periodontitis to observe their effects on periodontal bone repair. We found that the human β-defensin 3 gene-modified hPDLCs presented with high levels of osteogenesis-related gene expression and calcium deposition. Furthermore, the p38 MAPK pathway was activated in this process. In vivo, human β-defensin 3 gene-transfected rat PDLCs promoted bone repair in SD rats with periodontitis, and the p38 mitogen-activated protein kinase (MAPK) pathway might also have been involved. These findings demonstrate that human β-defensin 3 accelerates osteogenesis and that human β-defensin 3 gene modification may offer a potential approach to promote bone repair in patients with periodontitis.

References

[1] Redlich K, Smolen JS. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat. Rev. Drug Discov., 2012, 11: 234-250.

[2] Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol., 2015, 15: 30-44.

[3] GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 2017, 390: 1211-1259.

[4] Zhou X, . Oral health in China: from vision to action. Int. J. Oral Sci., 2018, 10: 1.

[5] Zhang X, . Local icariin application enhanced periodontal tissue regeneration and relieved local inflammation in a minipig model of periodontitis. Int. J. Oral Sci., 2018, 10: 19.

[6] Bassir SH, . Potential for stem cell-based periodontal therapy. J. Cell. Physiol., 2016, 231: 50-61.

[7] Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem., 2001, 276: 5707-5713.

[8] Dhople V, Krukemeyer A, Ramamoorthy A. The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochim. Biophys. Acta, 2006, 1758: 1499-1512.

[9] Zhang LJ, Gallo RL. Antimicrobial peptides. Curr. Biol., 2016, 26: R14-R19.

[10] Brown KL, Hancock RE. Cationic host defense (Antimicrobial) peptides. Curr. Opin. Immunol., 2006, 18: 24-30.

[11] Semple F, . Human beta-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF. Eur. J. Immunol., 2011, 41: 3291-3300.

[12] Kiatsurayanon C, . Host defense (antimicrobial) peptide, human beta-defensin-3, improves the function of the epithelial tight-junction barrier in human keratinocytes. J. Invest. Dermatol., 2014, 134: 2163-2173.

[13] Wang H, Watanabe H, Ogita M, Ichinose S, Izumi Y. Effect of human beta-defensin-3 on the proliferation of fibroblasts on periodontally involved root surfaces. Peptides, 2011, 32: 888-894.

[14] Kraus D, . Human beta-defensins differently affect proliferation, differentiation, and mineralization of osteoblast-like MG63 cells. J. Cell. Physiol., 2012, 227: 994-1003.

[15] Abiko Y, . Role of beta-defensins in oral epithelial health and disease. Med. Mol. Morphol., 2007, 40: 179-184.

[16] Ebrahem MA. Expression of human beta defensins (HBDs) 1, 2 and 3 in gingival crevicular fluid of patients affected by localized aggressive periodontitis. Saudi Dent. J., 2013, 25: 75-82.

[17] Bedran TB, Mayer MP, Spolidorio DP, Grenier D. Synergistic anti-inflammatory activity of the antimicrobial peptides human beta-defensin-3 (hBD-3) and cathelicidin (LL-37) in a three-dimensional co-culture model of gingival epithelial cells and fibroblasts. PLoS ONE, 2014, 9

[18] Cui D, . Human beta-defensin 3 inhibits periodontitis development by suppressing inflammatory responses in macrophages. Mol. Immunol., 2017, 91: 65-74.

[19] Lyu J, . Beta-defensin 3 modulates macrophage activation and orientation during acute inflammatory response to Porphyromonas gingivalis lipopolysaccharide. Cytokine, 2017, 92: 48-54.

[20] Zhu M, Miao B, Zhu J, Wang H, Zhou Z. Transplantation of periodontal ligament cell sheets expressing human betadefensin3 promotes antiinflammation in a canine model of periodontitis. Mol. Med. Rep., 2017, 16: 7459-7467.

[21] Chen FM, Sun HH, Lu H, Yu Q. Stem cell-delivery therapeutics for periodontal tissue regeneration. Biomaterials, 2012, 33: 6320-6344.

[22] Han J, Menicanin D, Gronthos S, Bartold PM. Stem cells, tissue engineering and periodontal regeneration. Aust. Dent. J., 2014, 59: 117-130.

[23] Naldini L. Gene therapy returns to centre stage. Nature, 2015, 526: 351-360.

[24] Zheng C, Chen J, Liu S, Jin Y. Stem cell-based bone and dental regeneration: a view of microenvironmental modulation. Int. J. Oral Sci., 2019, 11: 23.

[25] Long H, . miR-381 modulates human bone mesenchymal stromal cells (BMSCs) osteogenesis via suppressing Wnt signaling pathway during atrophic nonunion development. Cell Death Dis., 2019, 10

[26] Yang J, . Bone morphogenetic protein 2-induced human dental pulp cell differentiation involves p38 mitogen-activated protein kinase-activated canonical WNT pathway. Int. J. Oral Sci., 2015, 7: 95-102.

[27] Lee HW, . Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK. J. Bone Miner. Res., 2008, 23: 1227-1237.

[28] Zhang J, Tao Z, Wang Y. Long noncoding RNA DANCR regulates the proliferation and osteogenic differentiation of human bone-derived marrow mesenchymal stem cells via the p38 MAPK pathway. Int. J. Mol. Med., 2018, 41: 213-219.

[29] Shen X, . Antibacterial and osteogenesis performances of LL37-loaded titania nanopores in vitro and in vivo. Int. J. Nanomed., 2019, 14: 3043-3054.

[30] Kittaka M, . The antimicrobial peptide LL37 promotes bone regeneration in a rat calvarial bone defect. Peptides, 2013, 46: 136-142.

[31] Guo S, . Periodontal-derived mesenchymal cell sheets promote periodontal regeneration in inflammatory microenvironment. Tissue Eng. Part A, 2017, 23: 585-596.

[32] Yoshihara A, Seida Y, Hanada N, Miyazaki H. A longitudinal study of the relationship between periodontal disease and bone mineral density in community-dwelling older adults. J. Clin. Periodontol., 2004, 31: 680-684.

[33] Liljestrand JM, . Lipopolysaccharide, a possible molecular mediator between periodontitis and coronary artery disease. J. Clin. Periodontol., 2017, 44: 784-792.

[34] Trubiani O, . Toll-like receptor 4 expression, interleukin-6, -8 and Ccl-20 release, and NF-KB translocation in human periodontal ligament mesenchymal stem cells stimulated with LPS-P. gingivalis. Eur. J. Inflamm., 2012, 10: 81-89.

[35] Jonsson D, Nebel D, Bratthall G, Nilsson BO. LPS-induced MCP-1 and IL-6 production is not reversed by oestrogen in human periodontal ligament cells. Arch. Oral Biol., 2008, 53: 896-902.

[36] Bian T, . Human β-defensin 3 suppresses Porphyromonas gingivalis lipopolysaccharide-induced inflammation in RAW 264.7 cells and aortas of ApoE-deficient mice. Peptides, 2016, 82: 92-100.

[37] Mohajeri M, Behnam B, Sahebkar A. Biomedical applications of carbon nanomaterials: drug and gene delivery potentials. J. Cell. Physiol., 2018, 234: 298-319.

[38] Patil A, . Nanotechnology derived nanotools in biomedical perspectives: an update. Curr. Nanosci., 2019, 15: 137-146.

[39] Arnberg N. Adenovirus receptors: implications for targeting of viral vectors. Trends Pharmacol. Sci., 2012, 33: 442-448.

[40] Schmid M, . Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control. Nat. Commun., 2018, 9

[41] Schneider-Futschik EK. Beyond cystic fibrosis transmembrane conductance regulator therapy: a perspective on gene therapy and small molecule treatment for cystic fibrosis. Gene Ther., 2019, 26: 354-362.

[42] Yang L, . Effects of adenoviral-mediated coexpression of bone morphogenetic protein-7 and insulin-like growth factor-1 on human periodontal ligament cells. J. Periodontal Res., 2010, 45: 532-540.

[43] Jonsson D, Nebel D, Bratthall G, Nilsson BO. The human periodontal ligament cell: a fibroblast-like cell acting as an immune cell. J. Periodontal Res., 2011, 46: 153-157.

[44] Liu Z, . Antimicrobial peptide combined with BMP2-modified mesenchymal stem cells promotes calvarial repair in an osteolytic model. Mol. Ther., 2018, 26: 199-207.

[45] Mangoni ML, McDermott AM, Zasloff M. Antimicrobial peptides and wound healing: biological and therapeutic considerations. Exp. Dermatol., 2016, 25: 167-173.

[46] Bindal P, Ramasamy TS, Kasim NHA, Gnanasegaran N, Chai WL. Immune responses of human dental pulp stem cells in lipopolysaccharide-induced microenvironment. Cell Biol. Int., 2018, 42: 832-840.

[47] Kong X, . GSK3beta is a checkpoint for TNF-alpha-mediated impaired osteogenic differentiation of mesenchymal stem cells in inflammatory microenvironments. Biochim. Biophys. Acta, 2013, 1830: 5119-5129.

Funding

the Project of Invigorating Health Care through Science, Technology, and Education (no. CXTDB2017014); Nanjing Clinical Research Center for Oral Diseases (no. 2019060009)